Health Management

Shift represents growing understanding of value of genetic testing for cancers. Find out who is receiving the test and why.

Corporate giants Amazon, Berkshire Hathaway, and JPMorgan Chase, partner to shake things up in U.S. employee healthcare.

Two new studies reveal that cost-restraints can keep patients from accessing life-preserving cancer drugs.

In partnership with the several big-name cancer centers, one company has commenced clinical trials. Find out how this cancer vaccine would work.

Reducing readmissions for chronic obstructive pulmonary disease (COPD) is an ongoing challenge for healthcare systems. Here’s how one is successful.

From State-led programs to innovative pharmacist-hospital partnerships, these programs are fighting to quell the epidemic.

How are generic prices changing, how will biosimilars impact costs, and what changes out of Washington should healthcare executives watch? Economics guru Joe Fuhr weighs in.

The high cost of specialty drugs continues to plague the healthcare industry. Here’s why.

Many providers are overlooking important steps that can help guide proper COPD treatment and therefore, reduce admissions and readmissions.

CMS unveiled a voluntary episode bundled payment model, Bundled Payments for Care Improvement Advanced (BPCI Advanced). Here’s six things experts want you to know

How did Trump’s actions in 2017 impact the health insurance marketplace and enrollment numbers? Find out.

Willis Towers Watson research finds a dramatic increase among employers seeking to differentiate their health and well-being programs for competitive advantage.

With influenza activity increasing sharply, here’s how healthcare executives can determine which health plan members are at risk for the flu.

Catherine Bollard, MD, discusses the success rate of CAR T-cell treatments, remaining obstacles, and top payer considerations.

Trump’s new proposal would broaden access to association health plans. Here’s six things to know.

More awareness and new state laws regarding end-of-life treatment are affecting treatment approaches. Here’s what you need to know.

The winds of change swept through healthcare in 2017. Here’s what 2018 could bring.

By recognizing and address the needs of the “whole person,” we have an opportunity to improve the health of people across the U.S. Here are two ways to do that.

With the right preventions in place, hospitals and healthcare executives will be well positioned to respond to these four risks in 2018.

A new survey has eye-opening findings about the status quo one-size-fits-all health plan.

Fifty percent of Americans have high blood pressure, per new guidelines. Here’s how those guidelines could affect medication utilization and healthcare spending.

Successful community initiatives are creating systems of care that bridge multiple programs to provide coordinated services to individuals with substance use disorders. Here are five.

Here’s your quick guide to understanding how CAR T-cell therapy could affect patients and payers.

A new report from Cardinal Health Specialty Solutions gives behind-the-scenes perspectives from oncologists about CAR-T cell therapies, biosimilars and AML therapies (or genomic medicines)

Simple strategies can improve the nutritional well-being of COPD patients and help them maintain their weight.